Hubei Gedian Humanwell Pharmaceutical Testosterone Undecanoate Hubei Gedian Humanwell Pharmaceutical Testosterone Undecanoate

X

Find Drugs in Development News & Deals for Testosterone Undecanoate

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
892
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Details:

LPCN 2401, an oral proprietary combination of anabolic androgen receptor agonist (Testosterone Undecanoate) and α-tocopherol, an antioxidant, is being investigated for the treament of obesity.


Lead Product(s): Testosterone Undecanoate,Vitamin E

Therapeutic Area: Nutrition and Weight Loss Product Name: LPCN 2401

Highest Development Status: Phase IIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 11, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Prime (testosterone undecanoate) is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Prime

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 12, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Verity will market TLANDO (testosterone undecanoate), the first and only oral testosterone replacement therapy in adult males indicated for conditions associated with a deficiency or absence of endogenous testosterone, in the United States and, if approved, in Canada.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Tlando

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Verity Pharmaceuticals Inc

Deal Size: $270.0 million Upfront Cash: $2.5 million

Deal Type: Licensing Agreement February 02, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Under the agreement, Verity Pharma will market Tlando (testosterone undecanoate), the first and only oral testosterone replacement therapy (TRT), in the United States and, if approved, in Canada.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Tlando

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Verity Pharmaceuticals Inc

Deal Size: $270.0 million Upfront Cash: $2.5 million

Deal Type: Licensing Agreement January 18, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Kyzatrex (testosterone undecanoate) is a proprietary oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: KYZATREX

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 09, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

KYZATREX™ (testosterone undecanoate) is a proprietary softgel oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Kyzatrex

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 18, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

The partnership aims at addressing the pressing global issue of hypogonadism through the launch of a comprehensive Early Access Program for Kyzatrex (testosterone undecanoate), a proprietary softgel oral formulation absorbed primarily via the lymphatic system.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Kyzatrex

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Marius Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership August 10, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Nebido (having testosterone undecanoate) is the only available injectable long-acting depot preparation of testosterone undecanoate, developed for the treatment of male hypogonadism.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Nebido

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Grunenthal

Deal Size: $498.1 million Upfront Cash: Undisclosed

Deal Type: Acquisition November 02, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Following a competitive auction process, Tolmar was selected as the winning bidder in the sale of JATENZO (testosterone undecanoate), and the sale was approved by the U.S. Bankruptcy Court for the District of Delaware.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Jatenzo

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Tolmar

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition October 27, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

JATENZO (testosterone undecanoate) is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Jatenzo

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 18, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

JATENZO (testosterone undecanoate capsules; C-III), is the most prescribed FDA-approved softgel treatment with a safe delivery to help reach and keep normal testosterone levels.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Jatenzo

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 18, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

KYZATREX™ (testosterone undecanoate) is a proprietary softgel oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Kyzatrex

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 21, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

KYZATREX™ is an oral testosterone replacement therapy ("TRT") indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone, also known as hypogonadism.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Kyzatrex

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 02, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Jatenzo

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 28, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Nebido (testosterone undecanoate) is used for male hypogonadism. It is used for treating clinical symptoms such as regression of secondary sexual characteristics, change in body composition, asthenia, reduced libido or erectile dysfunction due to low testosterone levels.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Nebido

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Grunenthal

Deal Size: $506.6 million Upfront Cash: Undisclosed

Deal Type: Acquisition July 14, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

JATENZO (testosterone undecanoate) is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Jatenzo

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 09, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

TLANDO (testosterone undecanoate) is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Tlando

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 07, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Halozyme and Antares will create a drug delivery and specialty product company. The Antares business consists of a best-in-class, auto injector and ENHANZE platform that offers broad licensing opportunity, with 3 commercial products including Tlando (testosterone undecanoate).


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Tlando

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Halozyme Therapeutics

Deal Size: $960.0 million Upfront Cash: $960.0 million

Deal Type: Acquisition May 24, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content